Success Metrics

Clinical Success Rate
88.9%

Based on 8 completed trials

Completion Rate
89%(8/9)
Active Trials
1(8%)
Results Posted
13%(1 trials)
Terminated
1(8%)

Phase Distribution

Ph not_applicable
1
8%
Ph phase_1
1
8%
Ph phase_2
1
8%
Ph phase_3
1
8%

Phase Distribution

1

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 2Efficacy & side effects
1(25.0%)
Phase 3Large-scale testing
1(25.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

1

trials recruiting

Total Trials

12

all time

Status Distribution
Active(1)
Completed(8)
Terminated(1)
Other(2)

Detailed Status

Completed8
unknown2
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
1
Success Rate
88.9%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (25.0%)
Phase 21 (25.0%)
Phase 31 (25.0%)
N/A1 (25.0%)

Trials by Status

recruiting18%
unknown217%
terminated18%
completed867%

Recent Activity

1 active trials
Showing 5 of 12
recruitingphase_2

Preventive Strategies for Early and Late Complications of Leptospirosis

NCT07127718
completed

Short-term Outcomes of Elective High-risk PCI With Extracorporeal Membrane Oxygenation Support: a Single-centre Registry

NCT05387902
completed

Analysis of Endotoxin Activity in Patients With ECMO

NCT03978728
completed

Outcome of COVID-19 Patients After Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome

NCT04383678
completed

"Treatment Use of ECMO In Pregnancy or Peripartum Patient."

NCT04144660
View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT07127718Phase 2

Preventive Strategies for Early and Late Complications of Leptospirosis

Recruiting
NCT05387902

Short-term Outcomes of Elective High-risk PCI With Extracorporeal Membrane Oxygenation Support: a Single-centre Registry

Completed
NCT03978728

Analysis of Endotoxin Activity in Patients With ECMO

Completed
NCT04383678

Outcome of COVID-19 Patients After Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome

Completed
NCT04144660

"Treatment Use of ECMO In Pregnancy or Peripartum Patient."

Completed
NCT03021538

Bypass vs. Ecmo in Lung Transplantation (BELT)

Terminated
NCT03979222

Observational Cohort Study of a National Extracorporeal Membrane Oxygenation Service for Adults With Respiratory Failure: the NHS ECMO Study.

Completed
NCT04045873Not Applicable

PIONEER Trial:Hemodynamic Support With ECMO and IABP in Elective Complex High-risk PCI

Unknown
NCT03857217

Post-Cardiotomy Extra-Corporeal Life Support Study

Unknown
NCT02627378Phase 1

Saudi Outcomes of ECMO-treated MERS-CoV Patients

Completed
NCT00000562Phase 3

Extracorporeal Support for Respiratory Insufficiency (ECMO)

Completed
NCT00173615

Extracorporeal Membrane Oxygenation Effect in Prolonged Cardiopulmonary Resuscitation

Completed

All 12 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
12